648 692
Prostate Cancer
Reporting Magnetic Resonance Imaging in Men on Active
Surveillance for Prostate Cancer: The PRECISE
Recommendations—A Report of a European School of Oncology
Task Force
Caroline M. Moore
a , b , * ,z
, Francesco Giganti
c , d ,z
, Peter Albertsen
e ,Clare Allen
c ,Chris Bangma
f ,Alberto Briganti
g ,Peter Carroll
h ,Masoom Haider
i ,Veeru Kasivisvanathan
a , b ,Alex Kirkham
c ,Laurence Klotz
j ,Adil Ouzzane
k ,Anwar R. Padhani
l ,Valeria Panebianco
m ,Peter Pinto
n ,Philippe Puech
o ,Antti Rannikko
p ,Raphaele Renard-Penna
q ,Karim Touijer
r ,Baris Turkbey
s ,Heinrik van Poppel
t ,Riccardo Valdagni
u , v ,Jochen Walz
w, Ivo Schoots
xa
Division of Surgical and Interventional Science, University College London, London, UK;
b
Department of Urology, University College London Hospitals Trust,
London, UK;
c
Department of Radiology, University College London Hospital Trust, London, UK;
d
Department of Radiology and Centre for Experimental
Imaging, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy;
e
Division of Urology, University of Connecticut Health Center, Farmington, CT,
USA;
f
Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands;
g
Department of Urology, San Raffaele Scientific Institute,
Vita-Salute University, Milan, Italy;
h
Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,
San Francisco, CA, USA;
i
Department of Medical Imaging, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada;
j
Department of
Urology, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada;
k
Department of Urology, CHU Lille, Universite´ de Lille, Lille, France;
l
Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK;
m
Department of Radiological Sciences, Oncology and Pathology,
Prostate Unit Diagnostic University of Rome, ‘‘La Sapienza’’, Rome, Italy;
n
Urologic Oncology Branch, National Institutes of Health, National Cancer Institute,
Bethesda, MD, USA;
o
Department of Radiology, CHU Lille, Universite´ de Lille, Lille, France;
p
Department of Urology, Helsinki University Central Hospital,
Helsinki, Finland;
q
Department of Radiology, Pitie´-Salpetrie`re Hospital, AP-HP, UPMC Paris 06, Paris, France;
r
Urology Service, Department of Surgery,
Memorial Sloan Kettering Cancer Center, New York, NY, USA;
s
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda,
MD, USA;
t
Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium;
u
Radiation Oncology, Fondazione IRCSS Istituto Nazionale dei
Tumori, Milan, Italy;
v
Diagnostic Imaging and Radiotherapy, Universita` degli Studi di Milano, Milan, Italy;
w
Department of Urology, Institut Paoli-Calmettes,
Marseille, France;
x
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 6 4 8 – 6 5 5available at
www.scienced irect.comjournal homepage:
www.europeanurology.comArticle info
Article history:
Accepted June 9, 2016
Associate Editor:
James Catto
Keywords:
Prostate cancer
Prostate MRI
Active surveillance
Abstract
Background:
Published data on prostate magnetic resonance imaging (MRI) during
follow-up of men on active surveillance are lacking. Current guidelines for prostate MRI
reporting concentrate on prostate cancer (PCa) detection and staging. A standardised
approach to prostate MRI reporting for active surveillance will facilitate the robust
collection of evidence in this newly developing area.
Objective:
To develop preliminary recommendations for reporting of individual MRI
studies in men on active surveillance and for researchers reporting the outcomes of
cohorts of men having MRI on active surveillance.
Design, setting, and participants:
The RAND/UCLA Appropriateness Method was used.
Experts in urology, radiology, and radiation oncology developed a set of 394 statements
relevant to prostate MRI reporting in men on active surveillance for PCa. Each statement
z
These authors share first authorship.
* Corresponding author. Division of Surgical and Interventional Science, University College London, 3rd
Floor, Charles Bell House, 67-73 Riding House Street, London W1W7EJ, UK. Tel. +44 0 7817 431 668.
E-mail address:
caroline.moore@ucl.ac.uk(C.M. Moore).
http://dx.doi.org/10.1016/j.eururo.2016.06.0110302-2838/
#
2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.